Endurant Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-167,362
Closed -$12.6M 67
2021
Q1
$12.6M Buy
+167,362
New +$12.2M 3.28% 8
2019
Q2
Sell
-11,036
Closed -$595K 58
2019
Q1
$595K Sell
11,036
-136,593
-93% -$8.43M 0.24% 58
2018
Q4
$9.67M Buy
147,629
+56,211
+61% +$4.2M 5.11% 5
2018
Q3
$7.2M Sell
91,418
-15,655
-15% -$1.12M 3.2% 7
2018
Q2
$6.89M Buy
107,073
+2,962
+3% +$195K 2.99% 11
2018
Q1
$6.48M Buy
104,111
+50,811
+95% +$3.65M 2.42% 15
2017
Q4
$3.86M Buy
53,300
+25,800
+94% +$1.88M 1.18% 36
2017
Q3
$2.24M Sell
27,500
-20,800
-43% -$1.65M 0.68% 52
2017
Q2
$3.89M Sell
48,300
-9,800
-17% -$774K 1.1% 30
2017
Q1
$4.56M Buy
58,100
+11,600
+25% +$926K 1.47% 28
2016
Q4
$3.67M Buy
46,500
+16,817
+57% +$1.36M 1.52% 25
2016
Q3
$2.64M Buy
29,683
+18,298
+161% +$1.73M 0.98% 34
2016
Q2
$1.09M Buy
11,385
+2,885
+34% +$288K 0.36% 53
2016
Q1
$882K Sell
8,500
-16,400
-66% -$1.59M 0.29% 57
2015
Q4
$2.43M Buy
+24,900
New +$2.44M 0.81% 41
2015
Q3
Sell
-11,700
Closed -$1.23M 82
2015
Q2
$1.23M Buy
+11,700
New +$1.2M 0.36% 60

Other funds holding CVS

Endurant Capital Management's CVS Position: Q2 2021 in Review

Endurant Capital Management sold out of CVS Health (CVS) in Q2 2021, closing a stake of 167,362 shares — an estimated $12.6M sold.

Endurant Capital Management first reported a position in CVS in Q2 2015 and held it in 16 quarters. The position peaked at $12.6M in Q1 2021. 2,065 funds tracked by Wall St. Rank hold CVS as of Q2 2021.

  • Endurant Capital Management reported no remaining CVS Health position as of Q2 2021 after selling out during the quarter.
  • Endurant Capital Management sold 167,362 CVS Health shares in Q2 2021, an estimated $12.6M.
  • Endurant Capital Management first reported a position in CVS Health in Q2 2015 and held it in 16 quarters.
  • Endurant Capital Management's CVS Health position peaked at $12.6M in Q1 2021.
  • 2,065 funds tracked by Wall St. Rank held CVS Health as of Q2 2021.

Based on Endurant Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.